Clinical Response and Safety of Alternating Daily Dosage of Crizotinib due to Side Effects in Advanced NSCLC patient harboring ROS1-rearrangement: A Case Report. Jurnal Respirologi Indonesia, [S. l.], v. 43, n. 2, p. 111–115, 2023. DOI: 10.36497/jri.v43i2.201. Disponível em: http://jurnalrespirologi.org/index.php/jri/article/view/201. Acesso em: 14 aug. 2025.